Oaktree Provides $250MM Term Loan Facility to Seres Therapeutics - News
Seres Therapeutics, a leading microbiome therapeutics company, entered into a new $250 million senior secured debt facility ("Term Loan Facility") provided by funds managed by Oaktree Capital Management. The Company drew the first tranche of $110 million at closing, with three additional tranches available. These additional tranches include $90...